We love hearing from clinics around the UK who are stocking Emepelle® and seeing great results for their clients. One clinic owner we spoke to is Debbie Swindell, owner of Rejuve Aesthetics in Sheffield.
With a medical background in research ethics and safety, Debbie has worked in the skincare industry for over 14 years. At Rejuve Aesthetics, she offers a range of advanced aesthetic treatments such as PRP, Botox, fillers and radiofrequency.
While she offers a range of different treatments from her clinic, Debbie encourages her clients to implement a good skincare routine at home too. She believes the routine women complete at home accounts for around 60 per cent of their total skincare regime. This is why she recommends Emepelle® to clients who are perimenopausal, menopausal and post-menopausal and also uses Emepelle® herself.
We had a chat with Debbie about her experiences using Emepelle® and how she has introduced this revolutionary new skincare range to clients whose skin has been affected by declining oestrogen levels during menopause. Watch the video here.
In the video, Debbie explains how she conducts individual assessments with clients to determine how decreasing oestrogen levels may be affecting the skin.
The assessments give Debbie the opportunity to explain to the client exactly how menopause causes increased collagen loss and skin ageing, leading to increased dryness, lines and wrinkles, and dullness. Using this approach means Debbie’s clients can engage much more readily in the treatment programme she recommends.
In the video Debbie also shares with us:
- Why she’s getting so many questions about her own skincare regime since using Emepelle herself
- How she introduces Emepelle to clients, while explaining the effects of collagen loss during menopause
- How Emepelle’s broad appeal makes it ideal for a wide client base from women who are perimenopausal in their mid-30s to women who are post-menopausal.
- Why it’s important to Debbie that Emepelle® is evidence based
After recommending Emepelle® to several clients, Debbie has received fantastic feedback from both perimenopausal and menopausal clients.
She told us: “I’ve given Emepelle® out to quite a few of my clients; perimenopausal and postmenopausal and the feedback that I’ve been given is wonderful. It’s increased their self-confident but they actually feel more alive with their skin. It’s brighter with a reduction in little vessels. It’s more luminous and skin laxity is clearly tightening with a reduction in fine lines and wrinkles.”
The opportunity Emepelle® offers your clinic
If like Debbie, you’d like a clinically tested product you can confidently recommend to women who are perimenopausal or menopausal, Emepelle® is a great option.
Featuring revolutionary MEP Technology®, Emepelle® is clinically proven to significantly improve the visible signs of skin ageing caused by menopause.
MEP Technology® is a new class of cosmeceutical ingredient. It works on the skin cells fibroblasts and keratinocytes, to promote and activate new oestrogen receptors. This helps restore collagen, hyaluronic acid and epidermal thickness in skin affected by menopause, without systemic effect.
Emepelle® offers much more than other advanced anti-ageing products. It’s the only cosmeceutical to feature MEP Technology®, making it an innovative and unique choice for your clients. It’s clinically proven to effectively and safely target the root cause of accelerated collagen loss and skin ageing due to declining oestrogen levels.
Let’s talk about menopause
Emepelle® makes it easy for you to talk confidently about menopause with your customers while introducing a product they can easily incorporate into their daily routines. With a daytime serum and a rich night cream, the Emepelle® range offers a great return on investment for your clinic.
Plus, when you become an Emepelle® stockist, we’ll provide all the information you need to educate your clients about how menopause affects the skin. This gives you the opportunity to show your expertise, and become a trusted advisor for your clients as they approach and go through menopause.
